BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Dupont, Ironwood, Pioneer Natural

Tue Apr 26, 2016 1:24pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, Wall Street pared early gains and was little changed in late morning trading on Tuesday, weighed down by quarterly results of Dow components 3M and Procter & Gamble. The Dow Jones industrial average was down 0.02 percent at 17,972.83, the S&P 500 was up 0.09 percent at 2,089.7 and the Nasdaq Composite was down 0.14 percent at 4,889.089.

** SAREPTA THERAPEUTICS INC, $11.15, -25.42 pct

An experimental drug, from Sarepta, to treat Duchenne muscular dystrophy, a devastating degenerative disease that mostly affects boys, has not been proven effective, a U.S. advisory panel concluded on Monday. Oppenheimer cuts stock to "perform" from "outperform", Suntrust Robinson to "reduce" from "neutral", Piper Jaffray cuts to "underweight".


British drugmaker AstraZeneca Plc said on Tuesday Ironwood Pharmaceuticals would buy the U.S. marketing rights for its newly approved gout drug for up to $265 million.

** ARATANA THERAPEUTICS INC, $7.11, +2.89 pct

The pet drug developer said Eli Lilly and Co unit Elanco Animal Health was licensed rights to its galliprant tablets, an FDA-approved therapeutic for the control of pain and inflammation associated with osteoarthritis in dogs.

** T-MOBILE US INC, $39.8, -3.35 pct   Continued...